EA201171295A1 - Тестирование посторонних веществ - Google Patents
Тестирование посторонних веществInfo
- Publication number
- EA201171295A1 EA201171295A1 EA201171295A EA201171295A EA201171295A1 EA 201171295 A1 EA201171295 A1 EA 201171295A1 EA 201171295 A EA201171295 A EA 201171295A EA 201171295 A EA201171295 A EA 201171295A EA 201171295 A1 EA201171295 A1 EA 201171295A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- active substance
- composition
- testing
- relates
- absence
- Prior art date
Links
- 239000000126 substance Substances 0.000 title abstract 4
- 238000012360 testing method Methods 0.000 title abstract 4
- 102000040430 polynucleotide Human genes 0.000 abstract 6
- 108091033319 polynucleotide Proteins 0.000 abstract 6
- 239000002157 polynucleotide Substances 0.000 abstract 6
- 239000013543 active substance Substances 0.000 abstract 5
- 239000000203 mixture Substances 0.000 abstract 4
- 238000000034 method Methods 0.000 abstract 2
- 241001465754 Metazoa Species 0.000 abstract 1
- 239000012678 infectious agent Substances 0.000 abstract 1
- 229960003971 influenza vaccine Drugs 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 244000005700 microbiome Species 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000009261 transgenic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Mycology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Pulmonology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Изобретение относится к области фармацевтической промышленности и описывает способ тестирования посторонних веществ в композиции, включающей по меньшей мере одно активное вещество, включающий стадии: а) взаимодействия антитела, которое было продуцировано против продукта экспрессии полинуклеотидной конструкции, включающего последовательность, кодирующую по меньшей мере часть активного вещества, с композицией, включающей по меньшей мере одно активное вещество, где антитело связывается с активным веществом; и b) определения наличия или отсутствия посторонних веществ в композиции вслед за стадией а). Более того, изобретение описывает способ получения фармацевтической композиции путем выполнения указанного способа к использованию полинуклеотидной конструкции для тестирования наличия или отсутствия активного вещества или любого постороннего или инфекционного агента в тестируемой композиции. Изобретение также относится к определенным полинуклеотидам и полинуклеотидным конструкциям в качестве пригодных веществ в области противогриппозных вакцин, а также организмам, отличным от человека, трансгенным животным или микроорганизмам, содержащим полинуклеотиды и/или полинуклеотидные конструкции. Изобретение также относится к набору из частей.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US18183509P | 2009-05-28 | 2009-05-28 | |
| EP09161368 | 2009-05-28 | ||
| PCT/EP2010/057221 WO2010136476A1 (en) | 2009-05-28 | 2010-05-26 | Extraneous agents testing |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EA201171295A1 true EA201171295A1 (ru) | 2012-05-30 |
Family
ID=41259455
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA201171295A EA201171295A1 (ru) | 2009-05-28 | 2010-05-26 | Тестирование посторонних веществ |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US20120137378A1 (ru) |
| EP (1) | EP2435074B1 (ru) |
| JP (2) | JP6174857B2 (ru) |
| KR (1) | KR20120044293A (ru) |
| CN (1) | CN103298486B (ru) |
| AR (1) | AR076704A1 (ru) |
| AU (1) | AU2010251950B2 (ru) |
| CA (1) | CA2762260A1 (ru) |
| DK (1) | DK2435074T3 (ru) |
| EA (1) | EA201171295A1 (ru) |
| ES (1) | ES2563678T3 (ru) |
| IL (1) | IL216347A0 (ru) |
| MX (1) | MX2011012587A (ru) |
| MY (1) | MY183405A (ru) |
| PL (1) | PL2435074T3 (ru) |
| TW (2) | TWI597499B (ru) |
| UA (1) | UA110195C2 (ru) |
| WO (1) | WO2010136476A1 (ru) |
| ZA (1) | ZA201108539B (ru) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20160304586A1 (en) * | 2013-12-05 | 2016-10-20 | Crucell Holland B.V. | Process for preparing influenza vaccines |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1335429C (en) * | 1986-03-07 | 1995-05-02 | Geoffrey L. Smith | Processes for the production of hcmv glycoproteins, antibodies thereto and hcmv vaccines, and recombinant vectors therefor |
| JPH10257882A (ja) * | 1997-01-17 | 1998-09-29 | B M L:Kk | モノクローナル抗体の製造方法 |
| US20040053388A1 (en) * | 2002-01-03 | 2004-03-18 | Eckert Jorg H. | Detection of protein conformation using a split ubiquitin reporter system |
| CA2374388C (en) * | 2002-02-28 | 2005-07-12 | Matthew C. Coffey | The use of ribozymes in the detection of adventitious agents |
| US7510719B2 (en) * | 2004-12-08 | 2009-03-31 | Medimmune, Llc | Methods of producing influenza vaccine compositions |
| SG2014012868A (en) * | 2005-10-18 | 2014-09-26 | Novavax Inc | Functional influenza virus like particles (vlps) |
| JP2009519010A (ja) * | 2005-11-28 | 2009-05-14 | アイビス バイオサイエンシズ インコーポレイティッド | 外来混入ウイルスの同定に使用するための組成物 |
| JP2009067678A (ja) * | 2005-12-07 | 2009-04-02 | Nihon Nosan Kogyo Kk | 結合組織増殖因子に対する抗体又はそれを含む組成物 |
| CU23576A1 (es) * | 2006-02-28 | 2010-09-30 | Ct Ingenieria Genetica Biotech | Antígenos vacunales quiméricos contra el virus de la influenza aviar |
| WO2008124331A1 (en) * | 2007-04-03 | 2008-10-16 | Cytogenix, Inc. | Novel sequences and dna vaccines against avian flu |
-
2010
- 2010-05-25 TW TW099116688A patent/TWI597499B/zh active
- 2010-05-25 TW TW106118536A patent/TW201738562A/zh unknown
- 2010-05-26 EA EA201171295A patent/EA201171295A1/ru unknown
- 2010-05-26 ES ES10724012.9T patent/ES2563678T3/es active Active
- 2010-05-26 UA UAA201114035A patent/UA110195C2/uk unknown
- 2010-05-26 CA CA2762260A patent/CA2762260A1/en not_active Abandoned
- 2010-05-26 EP EP10724012.9A patent/EP2435074B1/en active Active
- 2010-05-26 CN CN201080023595.2A patent/CN103298486B/zh not_active Expired - Fee Related
- 2010-05-26 AR ARP100101804A patent/AR076704A1/es unknown
- 2010-05-26 US US13/322,887 patent/US20120137378A1/en not_active Abandoned
- 2010-05-26 MX MX2011012587A patent/MX2011012587A/es active IP Right Grant
- 2010-05-26 KR KR1020117028435A patent/KR20120044293A/ko active IP Right Grant
- 2010-05-26 WO PCT/EP2010/057221 patent/WO2010136476A1/en active Application Filing
- 2010-05-26 MY MYPI2011005656A patent/MY183405A/en unknown
- 2010-05-26 JP JP2012512349A patent/JP6174857B2/ja not_active Expired - Fee Related
- 2010-05-26 AU AU2010251950A patent/AU2010251950B2/en active Active
- 2010-05-26 DK DK10724012.9T patent/DK2435074T3/en active
- 2010-05-26 PL PL10724012.9T patent/PL2435074T3/pl unknown
-
2011
- 2011-11-14 IL IL216347A patent/IL216347A0/en unknown
- 2011-11-21 ZA ZA2011/08539A patent/ZA201108539B/en unknown
-
2015
- 2015-09-07 JP JP2015175659A patent/JP2016028581A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CN103298486B (zh) | 2016-10-05 |
| TW201043959A (en) | 2010-12-16 |
| ES2563678T3 (es) | 2016-03-15 |
| IL216347A0 (en) | 2012-01-31 |
| EP2435074A1 (en) | 2012-04-04 |
| UA110195C2 (en) | 2015-12-10 |
| JP6174857B2 (ja) | 2017-08-02 |
| JP2016028581A (ja) | 2016-03-03 |
| CA2762260A1 (en) | 2010-12-02 |
| KR20120044293A (ko) | 2012-05-07 |
| WO2010136476A1 (en) | 2010-12-02 |
| AU2010251950B2 (en) | 2014-12-18 |
| EP2435074B1 (en) | 2015-11-25 |
| AU2010251950A1 (en) | 2011-12-22 |
| US20120137378A1 (en) | 2012-05-31 |
| TW201738562A (zh) | 2017-11-01 |
| ZA201108539B (en) | 2012-07-25 |
| AR076704A1 (es) | 2011-06-29 |
| TWI597499B (zh) | 2017-09-01 |
| DK2435074T3 (en) | 2016-02-29 |
| MX2011012587A (es) | 2012-03-26 |
| MY183405A (en) | 2021-02-18 |
| CN103298486A (zh) | 2013-09-11 |
| JP2012527874A (ja) | 2012-11-12 |
| PL2435074T3 (pl) | 2016-09-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO7151488A2 (es) | Anticuerpos de reacción cruzada anti-jagged1/jagged 2, anticuerpos anti-jagged activables y métodos de uso de los mismos | |
| CY1117563T1 (el) | Αντισωματα κατα her3 και χρησεις αυτων | |
| BR112014006822A2 (pt) | proteínas de ligação ao antígeno cd27l | |
| EA200970255A1 (ru) | Связывающие молекулы человека, способные нейтрализовать вирус гриппа h5n1, и их применение | |
| CL2013001673A1 (es) | Composicion acuosa que comprende aproximadamente 18% p/v de concentracion, donde al menos el 95% de las proteinas son igg; metodo mejorado para preparar dicha composición. | |
| EA201591131A1 (ru) | Днк-конструкции антитела и способ их применения | |
| BR112012028920A2 (pt) | formulações de anticorpo de alta concentração | |
| CR20110204A (es) | Moleculas de anticuerpo mejoradas | |
| DK201100184U1 (da) | Method for immunizing an avian species | |
| BR112013009083A2 (pt) | anticorpos humanos de oncostatin m e métodos de uso | |
| BRPI0906478B8 (pt) | anticorpo anti-nr10, seu uso e composição farmacêutica que o compreende | |
| BR112017013956B8 (pt) | Proteínas de fusão de citocinas | |
| EA202090097A1 (ru) | Способ оценки эффектов композиции, содержащей микроорганизмы, на кишечную микробиоту | |
| BR112013009713A2 (pt) | método para identificação de alta produtividade antagonistas microbianos contra patógenos | |
| BR112016009460A8 (pt) | método para detectar a presença de anticorpos neutralizantes, e, kit | |
| CY1119873T1 (el) | Βελτιωμενα διαγνωστικα εμβολιου | |
| EA201300126A1 (ru) | Способ повышения активности активированной-потенцированной формы антител | |
| WO2013167727A3 (en) | Method for determining arthritis relapse risk | |
| EA201400571A1 (ru) | Специфичные к трансресвератролу антитела и их применение | |
| EA201171295A1 (ru) | Тестирование посторонних веществ | |
| CO7101191A2 (es) | Método de preparación de antobiótico novedoso y sistema de plataforma con base en el mismo | |
| GB2541596A (en) | Method and composition for determining specific antibody responses to species of filovirus | |
| SG10201907690TA (en) | Device and method for detecting target molecules | |
| ECSP11010772A (es) | Inhibidor de infección | |
| EA201401101A1 (ru) | Способ лабораторной диагностики пневмонии |